Delivery Order SPE2DB20D3101-SPE2DB25FRMT2
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCL ER 10 mg tablets. The contract is a firm fixed price, non-set-aside award with a ceiling value of $1,466.08 and a performance period ending on April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets in 90-count quantities. The contract has a ceiling value of $1,394.27 and a completion date of May 22, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCl ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a firm fixed price of $14,241.33 and a completion date of June 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,824.49 firm fixed-price contract is for the supply of Alfuzosin HCl ER 10 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCl ER 10 mg tablets. The delivery order is valued at $2,592.98 and has a period of performance through May 8, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4,563,711,620 units of Alfuzosin HCL ER 10 mg tablets, with a potential value of $1,878.00 and a completion date of February 9, 2024. This delivery order is placed under an Indefinite Delivery Contract (IDC) awarded...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,564,055,579 units of the pharmaceutical product Alfuzosin HCL ER 10 MG Tablet in 120 count packages, with a ceiling value of $32,675.45. The order has an ultimate completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCl ER 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a firm fixed price of $6,005.91 and a completion date of June 10, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,863,575 units of Alfuzosin HCL ER 10 mg tablets, with a ceiling value of $16,832.49. The contract has a period of performance through September 19, 2024 and uses a Firm Fixed Price pricing structure. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4564110624 - Alfuzosin HCl ER 10 mg Tablets in 90-count packages. The contract has a ceiling value of $4,816.46 and a period of performance through March 29, 2024. This delivery order is placed against an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen...